Predictive parameters for imatinib failure in patients with chronic myeloid leukemia.
CONCLUSION: The new score allows better selection of patients who are suitable for treatment with imatinib and may guideline the clinical decision for front-line treatment of CML.
PMID: 28327053 [PubMed - as supplied by publisher]
Source: Hematology - Category: Hematology Tags: Hematology Source Type: research
More News: Cancer & Oncology | Chronic Leukemia | Chronic Myeloid Leukaemia | Gleevec | Hematology | Hepatomegaly | Leukemia | Nilotinib | Study | Tasigna